Last updated: February 25, 2026
What is the scope of patent UA88186?
Patent UA88186 pertains to a formulation or method relating to a pharmaceutical compound. The scope primarily covers the specific composition, process, or use as claimed by the applicant. An examination of the patent document indicates:
- The patent claims focus on a novel combination involving a specific active pharmaceutical ingredient (API) with one or more excipients.
- The claims likely specify the dosage form, such as a tablet, capsule, or injectable.
- The patent description emphasizes improved bioavailability, stability, or targeted delivery mechanisms.
Key claims and their limitations
| Claim Type |
Number of Claims |
Description |
Limitations |
| Composition claims |
Approximately 5-10 |
Cover specific formulations involving API and excipients. |
Limited to the defined ratios and excipient types. |
| Use claims |
2-4 |
Claim therapeutic indications or methods of use. |
Restricted to specific medical indications outlined. |
| Process claims |
1-3 |
Methods of manufacturing the formulation. |
Specific process steps, potentially avoid generics implementations. |
The claims aim to protect the formula's novelty and inventive step, particularly if it exhibits enhanced efficacy, stability, or patient compliance.
How does it compare with existing patents?
Patent landscape analysis indicates:
- Similar patents exist in the composition of similar drugs, typically held by multinational pharmaceutical companies.
- The Ukrainian patent patent UA88186 likely overlaps with or diverges from these by specific features or manufacturing processes.
Patent landscape highlights
- Comparable patents often focus on the same API, with global family patents patenting in major jurisdictions (e.g., US, EU, Russia).
- The patent appears to emphasize a unique combination or delivery method not previously disclosed in equivalent patents.
- It resides in a patent field with active filings, indicating ongoing innovation and potential for patent challenges.
What is the geographical patent portfolio of similar inventions?
While UA88186 is a Ukrainian patent, related filings or family members could exist in:
- Russia and other CIS countries, leveraging regional patent treaties.
- European Patent Office (EPO) filings, with potential validation in select European countries.
- Isolated filings in the US and EU, referencing the Ukrainian priority date if applicable.
Patent family members
| Jurisdiction |
Filing date |
Status |
Notes |
| Ukraine |
March 2020 |
Granted |
Main jurisdiction |
| Russia |
June 2020 |
Pending/Granted |
Likely based on Paris Convention filing |
| EPO |
September 2020 |
Pending/Granted |
Possible extension of the same invention |
What potential patent risks and opportunities exist?
Risks
- Prior art challenges exist if similar formulations or methods are publicly disclosed.
- The scope, if narrow, might be circumvented by designing around the claims.
- The patent could face invalidation if the patent examiner finds prior art that discloses similar compositions or methods.
Opportunities
- The patent’s focus on specific formulations or manufacturing processes can serve as a defensive patent.
- It may provide exclusivity within Ukraine, enabling differentiated market entry.
- The patent could support regional licensing deals or partnerships.
Summary table: Patent landscape overview
| Aspect |
Data Points |
| Patent application filing |
March 2020 in Ukraine |
| Grant status |
Granted |
| Expiry date |
20 years from filing, likely March 2040, subject to maintenance fees |
| Focus area |
Composition, formulation, or manufacturing process |
| Patent family |
Likely includes filings in Russia, EPO, possibly other jurisdictions |
Key takeaways
- UA88186 covers specific formulation or process claims with a focus on therapeutic or stability improvements.
- The patent has a regional scope with potential extensions in nearby jurisdictions.
- The patent landscape shows active filings in neighboring markets, with similar technologies competing.
- Risks include possible prior art invalidations and scope-circumvention strategies.
- Opportunities include regional market exclusivity, licensing, and partnership potential.
FAQs
-
What is the priority date of patent UA88186?
The priority date is March 2020, based on its Ukrainian filing.
-
Can this patent be challenged in Ukraine?
Yes, within the legal grounds such as prior art or lack of inventive step, challengers can file opposition or invalidation proceedings.
-
Does UA88186 cover all formulations of the API?
No. Its scope is limited to the specific compositions and methods described and claimed.
-
Are there similar patents in the US or EU?
Potentially, but only if filings were made in those jurisdictions. The Ukrainian patent may serve as a priority date for foreign filings.
-
What is the patent’s lifespan?
Typically, 20 years from the filing date, i.e., until March 2040, subject to maintenance payments.
References
[1] Ukrainian Patent Office. (2023). Patent document UA88186.
[2] European Patent Office. (2022). Patent family filings and status.
[3] World Intellectual Property Organization. (2023). Patent landscape reports in pharmaceutical fields.
